pyrroles has been researched along with Hemangioblastoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gállego Pérez-Larraya, J; Reyes-Botero, G; Sanson, M | 1 |
| Davis, DW; Fuller, GN; Gombos, DS; Jonasch, E; Matin, SF; McCutcheon, IE; Smith, LA; Tannir, NM; Waguespack, SG; Wen, S | 1 |
| Aiello, LP; Cahill, MT; Cavallerano, J; George, DJ; Hannah, AL; Kaelin, WG; Wong, JS | 1 |
| Erginay, A; Gaudric, A; Girmens, JF; Massin, P; Richard, S; Scigalla, P | 1 |
| Adams, C; Braybrooke, JP; Cattell, E; Deplanque, G; Frith, P; Harris, AL; Huson, SM; Madhusudan, S; Moore, N; Price, P; Scigalla, P; Taylor, M; Tsaloumas, MD | 1 |
| de Wit, M; Fiedler, W; Höltje, J; Hossfeld, DK; Jacobs, MS; Laack, E; Schilling, G; Schuch, G; Scigalla, P | 1 |
2 trial(s) available for pyrroles and Hemangioblastoma
| Article | Year |
|---|---|
Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease.
Topics: Adult; Antineoplastic Agents; Carcinoma, Renal Cell; Female; Hemangioblastoma; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Pilot Projects; Pyrroles; Radiography; Sunitinib; Treatment Outcome; von Hippel-Lindau Disease; Young Adult | 2011 |
Antiangiogenic therapy for von Hippel-Lindau disease.
Topics: Adult; Angiogenesis Inhibitors; Brain Neoplasms; Female; Hemangioblastoma; Humans; Indoles; Male; Middle Aged; Pyrroles; Retinal Neoplasms; Spinal Cord Neoplasms; Treatment Outcome; Vascular Endothelial Growth Factor A; von Hippel-Lindau Disease | 2004 |
4 other study(ies) available for pyrroles and Hemangioblastoma
| Article | Year |
|---|---|
Sporadic CNS hemangioblastomatosis, response to sunitinib and secondary polycythemia.
Topics: Adult; Antineoplastic Agents; Brain; Central Nervous System Neoplasms; Hemangioblastoma; Humans; Indoles; Magnetic Resonance Imaging; Male; Polycythemia; Pyrroles; Spinal Cord; Sunitinib | 2012 |
Rapid and durable recovery of visual function in a patient with von hippel-lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416.
Topics: Angiogenesis Inhibitors; Contrast Sensitivity; Female; Fluorescein Angiography; Hemangioblastoma; Humans; Indoles; Magnetic Resonance Imaging; Middle Aged; Optic Disk; Optic Nerve Neoplasms; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Recovery of Function; Visual Acuity; Visual Fields; von Hippel-Lindau Disease | 2002 |
Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas.
Topics: Adult; Angiogenesis Inhibitors; Female; Fluorescein Angiography; Hemangioblastoma; Humans; Indoles; Infusions, Intravenous; Macular Edema; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Retinal Neoplasms; Visual Acuity; von Hippel-Lindau Disease | 2003 |
Case 2. Hemangioblastomas: diagnosis of von Hippel-Lindau disease and antiangiogenic treatment with SU5416.
Topics: Angiogenesis Inhibitors; Biopsy, Needle; Cerebellar Neoplasms; Diagnosis, Differential; Follow-Up Studies; Hemangioblastoma; Humans; Immunohistochemistry; Indoles; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Pyrroles; Risk Assessment; Treatment Outcome; von Hippel-Lindau Disease | 2005 |